113 related articles for article (PubMed ID: 3114116)
1. Growth hormone release in children after cranial irradiation.
Lannering B; Albertsson-Wikland K
Horm Res; 1987; 27(1):13-22. PubMed ID: 3114116
[TBL] [Abstract][Full Text] [Related]
2. Sustained improvement in growth velocity and recovery from suboptimal growth hormone (GH) secretion after treatment with human pituitary GH-releasing hormone-(1-44)-NH2.
Lifshitz F; Lanes R; Pugliese M; Fort P; Perez I; Puentes S; Cervantes C; Gunczler P; Chasalow FI; Recker B
J Clin Endocrinol Metab; 1992 Nov; 75(5):1255-60. PubMed ID: 1430086
[TBL] [Abstract][Full Text] [Related]
3. Neurotransmitter control of growth hormone secretion in children after cranial radiation therapy.
Jorgensen EV; Schwartz ID; Hvizdala E; Barbosa J; Phuphanich S; Shulman DI; Root AW; Estrada J; Hu CS; Bercu BB
J Pediatr Endocrinol; 1993; 6(2):131-42. PubMed ID: 8102303
[TBL] [Abstract][Full Text] [Related]
4. Results of 1-year growth hormone (GH)-releasing hormone-(1-44) treatment on growth, somatomedin-C, and 24-hour GH secretion in six children with partial GH deficiency.
Rochiccioli PE; Tauber MT; Coude FX; Arnone M; Morre M; Uboldi F; Barbeau C
J Clin Endocrinol Metab; 1987 Aug; 65(2):268-74. PubMed ID: 3110202
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic studies with intravenous and intranasal growth hormone-releasing peptide-2 in children of short stature.
Pihoker C; Middleton R; Reynolds GA; Bowers CY; Badger TM
J Clin Endocrinol Metab; 1995 Oct; 80(10):2987-92. PubMed ID: 7559885
[TBL] [Abstract][Full Text] [Related]
6. Modification of 24-hour growth hormone secretion after continuous subcutaneous infusion of growth hormone-releasing hormone (GHRH (1-29)NH2) in short children with low 24-hour growth hormone secretion.
Tauber MT; Pienkowski C; Landier F; Gunnarsson R; Rochiccioli P
Acta Paediatr Scand Suppl; 1989; 349():117-22; discussion 123-4. PubMed ID: 2546370
[TBL] [Abstract][Full Text] [Related]
7. Effects of pulsatile administration of growth hormone (GH)-releasing hormone on short term linear growth in children with GH deficiency.
Gelato MC; Ross JL; Malozowski S; Pescovitz OH; Skerda M; Cassorla F; Loriaux DL; Merriam GR
J Clin Endocrinol Metab; 1985 Sep; 61(3):444-50. PubMed ID: 3926806
[TBL] [Abstract][Full Text] [Related]
8. The effects of testosterone and dihydrotestosterone on hypothalamic regulation of growth hormone secretion.
Eakman GD; Dallas JS; Ponder SW; Keenan BS
J Clin Endocrinol Metab; 1996 Mar; 81(3):1217-23. PubMed ID: 8772602
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone response to growth hormone-releasing hormone (hp GHRH1-44) as an index of growth hormone secretory dysfunction after prophylactic cranial irradiation for acute lymphoblastic leukemia (24 grays).
Crosnier H; Brauner R; Rappaport R
Acta Paediatr Scand; 1988 Sep; 77(5):681-7. PubMed ID: 3144116
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone (GH) release after administration of GH-releasing hormone in relation to endogenous 24-h GH secretion in short children.
Gelander L; Albertsson-Wikland K
J Endocrinol; 1989 Jul; 122(1):61-8. PubMed ID: 2549156
[TBL] [Abstract][Full Text] [Related]
11. The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval.
Darzy KH; Aimaretti G; Wieringa G; Gattamaneni HR; Ghigo E; Shalet SM
J Clin Endocrinol Metab; 2003 Jan; 88(1):95-102. PubMed ID: 12519836
[TBL] [Abstract][Full Text] [Related]
12. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
Ghigo E; Imperiale E; Boffano GM; Mazza E; Bellone J; Arvat E; Procopio M; Goffi S; Barreca A; Chiabotto P
J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
[TBL] [Abstract][Full Text] [Related]
13. The use of growth hormone-releasing hormone in the diagnosis and treatment of short stature.
Grossman A; Savage MO; Blacklay A; Ross RM; Plowman PN; Preece MA; Coy DH; Besser GM
Horm Res; 1985; 22(1-2):52-7. PubMed ID: 2863206
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone secretion and response to growth hormone therapy after treatment for brain tumour.
Lannering B; Marky I; Mellander L; Albertsson-Wikland K
Acta Paediatr Scand Suppl; 1988; 343():146-51. PubMed ID: 3143223
[TBL] [Abstract][Full Text] [Related]
15. Subcutaneous treatment with growth hormone-releasing hormone for short stature.
Hernández M; Fragoso J; Barrio R; Argente J; Arilla E
Horm Res; 1988; 30(6):252-7. PubMed ID: 2907992
[TBL] [Abstract][Full Text] [Related]
16. The effects of beta 1-adrenergic blockade on the growth response to growth hormone (GH)-releasing hormone therapy in GH-deficient children.
Cassorla F; Mericq V; García H; Cristiano A; Avila A; Boric A; Iñiguez G; Merriam GR
J Clin Endocrinol Metab; 1995 Oct; 80(10):2997-3001. PubMed ID: 7559887
[TBL] [Abstract][Full Text] [Related]
17. Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection.
Pombo M; Barreiro J; Peñalva A; Peino R; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1995 Nov; 80(11):3180-4. PubMed ID: 7593423
[TBL] [Abstract][Full Text] [Related]
18. Effect of overnight constant infusion of human growth hormone (GH)-releasing hormone-(1-44) on 24-hour GH secretion in children with partial GH deficiency.
Rochiccioli PE; Tauber MT; Uboldi F; Coude FX; Morre M
J Clin Endocrinol Metab; 1986 Nov; 63(5):1100-5. PubMed ID: 3093519
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency.
Tzanela M; Guyda H; Van Vliet G; Tannenbaum GS
J Clin Endocrinol Metab; 1996 Jul; 81(7):2487-94. PubMed ID: 8675565
[TBL] [Abstract][Full Text] [Related]
20. Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study.
Jaffe CA; Turgeon DK; Friberg RD; Watkins PB; Barkan AL
J Clin Endocrinol Metab; 1995 Nov; 80(11):3321-6. PubMed ID: 7593445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
